NeuroPace, Inc. (NPCE)
NASDAQ
Market Cap
$197.06M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
672 of 809
Rank in Industry
93 of 107
Largest Insider Buys in Sector
NPCE Stock Price History Chart
NPCE Stock Performance
About NeuroPace, Inc.
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
Insider Activity of NeuroPace, Inc.
Over the last 12 months, insiders at NeuroPace, Inc. have bought $0 and sold $9.67M worth of NeuroPace, Inc. stock.
On average, over the past 5 years, insiders at NeuroPace, Inc. have bought $12.85M and sold $4.85M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 62,398 shares for transaction amount of $93,535 was made by Accelmed Partners II L.P. (director) on 2022‑11‑22.
List of Insider Buy and Sell Transactions, NeuroPace, Inc.
| 2024-05-03 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 4,674 0.0167% | $14.03 | $65,576 | -49.63% | |
| 2024-05-02 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 8,842 0.031% | $14.01 | $123,876 | -50.29% | |
| 2024-05-01 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 15,690 0.0548% | $14.02 | $219,974 | -50.25% | |
| 2024-04-24 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 1,781 0.0063% | $14.06 | $25,041 | -44.17% | |
| 2024-04-23 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 21,791 0.0784% | $14.29 | $311,393 | -45.57% | |
| 2024-04-22 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 24,609 0.0871% | $14.05 | $345,756 | -44.46% | |
| 2024-04-19 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 18,253 0.0646% | $14.02 | $255,907 | -43.16% | |
| 2024-04-18 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 2,623 0.0093% | $14.06 | $36,879 | -43.14% | |
| 2024-04-17 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 300 0.0011% | $14.15 | $4,245 | -41.96% | |
| 2024-04-16 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 14,069 0.0495% | $14.01 | $197,107 | -43.16% | |
| 2024-04-12 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 23,101 0.0871% | $14.42 | $333,116 | -40.66% | |
| 2024-04-11 | Sale | ORBIMED ADVISORS LLC | 10 percent owner | 461,899 1.6279% | $14.49 | $6.69M | -44.66% | |
| 2024-02-05 | Sale | Morrell Martha | Chief Medical Officer | 3,446 0.0132% | $15.17 | $52,278 | -12.52% | |
| 2024-02-02 | Sale | Morrell Martha | Chief Medical Officer | 14,143 0.0539% | $15.07 | $213,122 | -10.36% | |
| 2024-02-01 | Sale | Morrell Martha | Chief Medical Officer | 663 0.0025% | $15.04 | $9,971 | -9.87% | |
| 2024-01-31 | Sale | Morrell Martha | Chief Medical Officer | 1,923 0.0073% | $15.08 | $28,990 | -7.56% | |
| 2024-01-30 | Sale | Morrell Martha | Chief Medical Officer | 11,262 0.043% | $15.10 | $170,004 | -10.14% | |
| 2024-01-25 | Sale | Morrell Martha | Chief Medical Officer | 1 <0.0001% | $15.00 | $15 | -6.97% | |
| 2024-01-24 | Sale | Morrell Martha | Chief Medical Officer | 827 0.0032% | $15.03 | $12,426 | -7.22% | |
| 2023-12-27 | Sale | Morrell Martha | Chief Medical Officer | 13,300 0.0513% | $10.12 | $134,648 | +31.99% |
Insider Historical Profitability
199.33%
| KCK LTD. | 10 percent owner | 5593773 21.2823% | $6.85 | 0 | 5 | |
| ORBIMED ADVISORS LLC | 10 percent owner | 3406335 15.2337% | $6.85 | 1 | 14 | |
| Morrell Martha | Chief Medical Officer | 77762 0.2959% | $6.85 | 0 | 11 | |
| Accelmed Partners II L.P. | director | 4432948 16.8658% | $6.85 | 3 | 0 | +199.33% |
| Norton Evan | director | 588235 2.238% | $6.85 | 1 | 0 | |
| Fischer Frank M | director | 93291 0.3549% | $6.85 | 1 | 0 | |
| Ridley Irina | General Counsel and Secretary | 61139 0.2326% | $6.85 | 1 | 2 | |
| Garfield Greg Shaw | director | 38853 0.1478% | $6.85 | 1 | 0 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| OrbiMed | $52.85M | 13.92 | 4M | 0% | +$0 | 1.08 | |
| Morgan Stanley | $32.79M | 8.63 | 2.48M | +0.95% | +$307,124.40 | <0.01 | |
| Soleus Capital Management, L.P. | $32.12M | 8.46 | 2.43M | 0% | +$0 | 0.31 | |
| Nantahala Capital Management Llc | $10.27M | 2.71 | 778,260 | -33.69% | -$5.22M | 1.05 | |
| Kent Lake Capital LLC | $8.5M | 2.24 | 643,629 | -4.07% | -$360,584.41 | 3.72 | |
| Millennium Management LLC | $8M | 2.11 | 605,713 | +251.34% | +$5.72M | 0.01 | |
| The Vanguard Group | $6.45M | 1.7 | 488,618 | +18.28% | +$996,758.31 | <0.0001 | |
| Fidelity Investments | $4M | 1.05 | 302,803 | -35.31% | -$2.18M | <0.0001 | |
| Susquehanna International Group | $2.69M | 0.71 | 203,776 | +381.91% | +$2.13M | <0.01 | |
| Goldman Sachs | $1.85M | 0.49 | 139,843 | New | +$1.85M | <0.0001 | |
| Renaissance Technologies | $1.58M | 0.42 | 119,971 | +10.75% | +$153,764.36 | <0.01 | |
| Geode Capital Management | $1.54M | 0.41 | 116,960 | +0.83% | +$12,727.65 | <0.0001 | |
| Citigroup | $999,082.00 | 0.26 | 75,688 | +116.12% | +$536,804.61 | <0.01 | |
| Eam Investors | $998,250.00 | 0.26 | 75,625 | +14.34% | +$125,188.80 | 0.16 | |
| BlackRock | $978,834.00 | 0.26 | 74,154 | -14.28% | -$162,993.80 | <0.0001 | |
| Jane Street Capital | $950,572.00 | 0.25 | 72,013 | +95.57% | +$464,521.40 | <0.01 | |
| Marshall Wace | $770,326.00 | 0.2 | 58,358 | +311.81% | +$583,268.70 | <0.01 | |
| Cubist Systematic Strategies | $669,570.00 | 0.18 | 50,725 | +344.37% | +$518,892.00 | 0.01 | |
| Acadian Asset Management | $621,000.00 | 0.16 | 47,215 | New | +$621,000.00 | <0.01 | |
| Qube Research & Technologies | $596,878.00 | 0.16 | 45,218 | +72.58% | +$251,011.37 | <0.01 | |
| Man Group Plc | $500,834.00 | 0.13 | 37,942 | +96.61% | +$246,100.60 | <0.01 | |
| State Street | $491,713.00 | 0.13 | 37,251 | +11.69% | +$51,479.98 | <0.0001 | |
| Bridgeway Capital Management | $438,240.00 | 0.12 | 33,200 | -2.06% | -$9,240.00 | 0.01 | |
| JPMorgan Chase | $423,918.00 | 0.11 | 32,115 | +182.7% | +$273,966.00 | <0.0001 | |
| Hrt Financial Llc | $421,000.00 | 0.11 | 31,921 | New | +$421,000.00 | <0.01 | |
| Northern Trust | $390,641.00 | 0.1 | 29,594 | -15.5% | -$71,649.64 | <0.0001 | |
| Marathon Trading Investment Management Llc | $369,600.00 | 0.1 | 28,000 | New | +$369,600.00 | 0.15 | |
| Balyasny Asset Management Llc | $355,740.00 | 0.09 | 26,950 | -0.76% | -$2,719.20 | <0.01 | |
| Jump Financial Llc | $337,102.00 | 0.09 | 25,538 | New | +$337,102.00 | <0.01 | |
| Petrus Trust Company Lta | $315,533.00 | 0.08 | 23,904 | New | +$315,533.00 | 0.03 | |
| Laurion Capital Management LP | $273,227.00 | 0.07 | 20,699 | 0% | +$0 | 0.01 | |
| Walleye Capital | $260,014.00 | 0.07 | 19,698 | +37.56% | +$70,989.71 | <0.01 | |
| ExodusPoint Capital Management, LP | $256,000.00 | 0.07 | 19,431 | -1.82% | -$4,742.94 | <0.01 | |
| Options Solutions Llc | $244,187.00 | 0.06 | 18,499 | New | +$244,187.00 | 0.14 | |
| Xtx Topco Ltd | $203,438.00 | 0.05 | 15,412 | New | +$203,438.00 | 0.01 | |
| Brevan Howard Capital Management Lp | $198,449.00 | 0.05 | 15,034 | New | +$198,449.00 | 0.02 | |
| Schonfeld Group | $190,422.00 | 0.05 | 14,426 | New | +$190,422.00 | <0.01 | |
| Barclays | $183,000.00 | 0.05 | 13,870 | -0.72% | -$1,332.59 | <0.0001 | |
| Bank of America | $180,919.00 | 0.05 | 13,706 | -57.04% | -$240,226.53 | <0.0001 | |
| Squarepoint Ops LLC | $175,771.00 | 0.05 | 13,316 | New | +$175,771.00 | <0.01 | |
| Hillsdale Investment Management Inc. | $155,100.00 | 0.04 | 11,750 | New | +$155,100.00 | 0.01 | |
| Jefferies Financial Group | $143,880.00 | 0.04 | 10,900 | New | +$143,880.00 | <0.01 | |
| Point72 Asia Singapore Pte Ltd | $137,003.00 | 0.04 | 10,379 | +3,938.52% | +$133,610.60 | 0.01 | |
| Y Intercept Hong Kong Ltd | $138,481.00 | 0.04 | 10,491 | New | +$138,481.00 | 0.01 | |
| Financial Advocates Investment Management | $132,000.00 | 0.04 | 10,000 | 0% | +$0 | <0.01 | |
| Citadel Advisors LLC | $107,580.00 | 0.03 | 8,150 | -66.12% | -$209,946.00 | <0.0001 | |
| Tower Research Capital | $49,672.00 | 0.01 | 3,763 | +1,393.25% | +$46,345.57 | <0.01 | |
| LAZARD ASSET MANAGEMENT LLC | $46,000.00 | 0.01 | 3,541 | -9.88% | -$5,040.38 | <0.0001 | |
| Wells Fargo | $27,482.00 | 0.01 | 2,082 | +2,470.37% | +$26,412.82 | <0.0001 | |
| UBS | $22,440.00 | 0.01 | 1,700 | New | +$22,440.00 | <0.0001 |